Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

News | VIVA

October 31, 2022 — Results from the Late-Breaking Clinical Trials session at The VEINS Conference in Las Vegas, NV, were ...

Home October 31, 2022
Home
News | Heart Failure

October 28, 2022 —  V-Wave, announced today the completion of enrollment in RELIEVE-HF, a prospective, randomized ...

Home October 28, 2022
Home
News | Drug-Eluting Balloons

October 28, 2022 —  SELUTION SLR, MedAlliance’s novel sirolimus-eluting balloon, has received FDA Investigational Device ...

Home October 28, 2022
Home
News | Endovascular Aortic Repair

October 26, 2022 —  Thousands of people have new hope for treatment of thoracic aortic arch disease and University ...

Home October 26, 2022
Home
News | Catheter

October 21, 2022 —  Medtronic plc, a global leader in healthcare technology, today announced it has received U.S. Food ...

Home October 21, 2022
Home
News | Cardiac Imaging

October 18, 2022 —  HeartFlow, Inc., a leader in revolutionizing precision heart care, has received U.S. Food and Drug ...

Home October 18, 2022
Home
News | Heart Valve Technology

October 18, 2022 —  The United States Food and Drug Administration (FDA) has granted 510(k) clearance to Abiomed for its ...

Home October 18, 2022
Home
News | Cardiovascular Surgery

October 17, 2022 —  Allegheny Health Network’s (AHN) Cardiovascular Institute announced the expansion of its nationally ...

Home October 17, 2022
Home
News | Drug-Eluting Balloons

October 18, 2022 — Swiss-based medical technology company MedAlliance has announced it has entered into an agreement ...

Home October 18, 2022
Home
News | Venous Therapies

October 14, 2022 —  Medtronic, a global leader in medical technology, announced the 36-month final results from the ABRE ...

Home October 14, 2022
Home
News | Stents Bioresorbable

October 11, 2022 —  Efemoral Medical, developer of advanced interventional bioresorbable therapies, announced that it ...

Home October 11, 2022
Home
The Impella CP with SmartAssist heart pump is a minimally invasive, temporary heart pump that uses real-time intelligence associated with improved survival and heart recovery. (Graphic: Business Wire)
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is a recap of what DAIC viewers found most interesting during the month of September:


1. Unloading with Impella ...

Home October 03, 2022
Home
News | Stents Bioresorbable

September 28, 2022 —  In the "TCT Innovation" session Prof. Michael Haude, BIOMAG-I Coordinating Clinical Investigator ...

Home September 28, 2022
Home
News | Pediatric Cardiology

September 28, 2022 —  Babies born with heart valve defects will have as many as 3 to 5 open heart surgeries before ...

Home September 28, 2022
Home
Subscribe Now